RESTRICTED STOCK UNIT CANCELLATION AGREEMENTRestricted Stock Unit Cancellation Agreement • January 10th, 2018 • Ignyta, Inc. • Pharmaceutical preparations • California
This RESTRICTED STOCK UNIT CANCELLATION AGREEMENT (this “Agreement”) is made this 5th day of January, 2018 (the “Effective Date”), between Ignyta, Inc., a Delaware corporation (the “Company”), and Jonathan E. Lim, M.D. (the “Holder”).
Ignyta, Inc.Ignyta, Inc. • January 10th, 2018 • Pharmaceutical preparations
We are pleased to inform you that, on December 21, 2017, Ignyta, Inc. (“Ignyta”) entered into a definitive Agreement and Plan of Merger (the “Merger Agreement”) with Roche Holdings, Inc. (“Parent”) and Abingdon Acquisition Corp., a wholly owned subsidiary of Parent (“Purchaser”). In accordance with the Merger Agreement, Purchaser has commenced on January 10, 2018, a tender offer (the “Offer”) to purchase all of the issued and outstanding shares of our common stock, par value $0.0001 per share (the “Shares”), at a price per Share of $27.00, net to the holder thereof in cash, without interest (the “Offer Price”) and subject to any withholding of taxes required by applicable law.
